Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice
- PMID: 8144886
Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice
Abstract
Cyclosporin A (CsA) is an immunosuppressive drug that inhibits TCR-mediated signal transduction. This drug has two major effects on developing alpha beta thymocytes in normal mice: it blocks the development of most mature CD4+8- and CD4-8+ thymocytes and inhibits the deletion of some but not all self-specific thymocytes. The latter effect may explain how CsA treatment can paradoxically induce autoimmunity in certain situations. Here we investigated the effects of CsA on thymocyte development in transgenic mice that express on most of their T cells an alpha beta TCR specific for male H-Y Ag bound to H-2 Db class I molecules, a model system in which positive and negative selection have been clearly defined. Positive selection occurs in female mice, resulting in the development of mature CD4-CD8+ T cells, whereas negative selection occurs in male mice, resulting in the deletion of self-reactive CD4+8+ thymocytes. CsA blocked positive selection, as evidenced by the finding that most of the cells present in the thymuses of CsA-treated female mice were functionally immature precursors that expressed heat-stable Ag. In male mice, CsA delayed but did not prevent the deletion of most CD4+8+ thymocytes. A few transgenic thymocytes, however, were not deleted and achieved the TCR+, CD4-8+ phenotype of positively selected cells. Therefore, for a small subset of thymocytes, CsA may convert a normally negatively selecting TCR signal to a positively selecting one.
Similar articles
-
Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium.J Immunol. 1992 May 15;148(10):2988-95. J Immunol. 1992. PMID: 1578126
-
CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.J Immunol. 1993 Jul 15;151(2):777-90. J Immunol. 1993. PMID: 8335907
-
Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.J Immunol. 1996 Nov 15;157(10):4379-89. J Immunol. 1996. PMID: 8906813
-
Negative and positive selection of immature thymocytes: timing and the role of the ligand for alpha beta T cell receptor.Semin Immunol. 1990 Jan;2(1):35-44. Semin Immunol. 1990. PMID: 2151796 Review.
-
Multiple effects of cyclosporin A on the thymus in relation to T-cell development and autoimmunity.Clin Immunol Immunopathol. 1997 Mar;82(3):197-202. doi: 10.1006/clin.1996.4254. Clin Immunol Immunopathol. 1997. PMID: 9073541 Review.
Cited by
-
Primary and secondary defects of the thymus.Immunol Rev. 2024 Mar;322(1):178-211. doi: 10.1111/imr.13306. Epub 2024 Jan 16. Immunol Rev. 2024. PMID: 38228406 Review.
-
Memory-phenotype CD4+ T cells spontaneously generated under steady-state conditions exert innate TH1-like effector function.Sci Immunol. 2017 Jun 16;2(12):eaam9304. doi: 10.1126/sciimmunol.aam9304. Sci Immunol. 2017. PMID: 28783663 Free PMC article.
-
PKCtheta is necessary for efficient activation of NFkappaB, NFAT, and AP-1 during positive selection of thymocytes.Immunol Lett. 2010 Aug 16;132(1-2):6-11. doi: 10.1016/j.imlet.2010.04.008. Epub 2010 Apr 28. Immunol Lett. 2010. PMID: 20433868 Free PMC article.
-
Infusion of nonmyeloablative bone marrow alleviates acute rejection reaction in liver allotransplantation.J Zhejiang Univ Sci B. 2005 Dec;6(12):1188-94. doi: 10.1631/jzus.2005.B1188. J Zhejiang Univ Sci B. 2005. PMID: 16358377 Free PMC article.
-
Defective T cell development and function in calcineurin A beta -deficient mice.Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9398-403. doi: 10.1073/pnas.152665399. Epub 2002 Jun 28. Proc Natl Acad Sci U S A. 2002. PMID: 12091710 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous